Device Trial Radar · NCT01952431
Measurement and Evaluation of Total Lung Capacity (TLC) in the Field of Pulmonary Functional Testing (PFT)
Last checked: Nov 19, 2026Latest source record: Nov 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Apr 2013
Primary completion
Sep 2013
Study completion Sep 2013
Sponsor
- Lead sponsor
- PulmOne Advanced Medical Devices, Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 30, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A comparative study to test the efficacy of a novel device - the MiniBoxPFT, in measuring TLC (total lung capacity) compared to TLC measured by standard body plethysmography using the ZAN 500. The study will be conducted as a prospective two-arm, open, randomized comparative study.
Conditions
- TLC in Patients With and Without Respiratory System Disease
Interventions
Total Lung Capacity (TLC) testingDevice
Comparison of TLC results
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Lung Capacity (TCL)Time frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rambam University Medical Center
Haifa, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.